231 related articles for article (PubMed ID: 15152076)
21. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
22. A Novel 18-Marker Panel Predicting Clinical Outcome in Breast Cancer.
Biermann J; Nemes S; Parris TZ; Engqvist H; Rönnerman EW; Forssell-Aronsson E; Steineck G; Karlsson P; Helou K
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1619-1628. PubMed ID: 28877888
[No Abstract] [Full Text] [Related]
23. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer.
Lee JK; Coutant C; Kim YC; Qi Y; Theodorescu D; Symmans WF; Baggerly K; Rouzier R; Pusztai L
Clin Cancer Res; 2010 Jan; 16(2):711-8. PubMed ID: 20068086
[TBL] [Abstract][Full Text] [Related]
25. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
26. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.
Gatza ML; Silva GO; Parker JS; Fan C; Perou CM
Nat Genet; 2014 Oct; 46(10):1051-9. PubMed ID: 25151356
[TBL] [Abstract][Full Text] [Related]
27. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
28. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer genomics: real-time use.
Bertucci F; Birnbaum D
Lancet Oncol; 2007 Dec; 8(12):1045-1047. PubMed ID: 18054870
[No Abstract] [Full Text] [Related]
30. Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.
Stühler E; Braune S; Lionetto F; Heer Y; Jules E; Westermann C; Bergmann A; van Hövell P;
BMC Med Res Methodol; 2020 Feb; 20(1):24. PubMed ID: 32028898
[TBL] [Abstract][Full Text] [Related]
31. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.
Barry WT; Kernagis DN; Dressman HK; Griffis RJ; Hunter JD; Olson JA; Marks JR; Ginsburg GS; Marcom PK; Nevins JR; Geradts J; Datto MB
J Clin Oncol; 2010 May; 28(13):2198-206. PubMed ID: 20368555
[TBL] [Abstract][Full Text] [Related]
32. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
[TBL] [Abstract][Full Text] [Related]
33. Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Karlsson E; Delle U; Danielsson A; Olsson B; Abel F; Karlsson P; Helou K
BMC Cancer; 2008 Sep; 8():254. PubMed ID: 18778486
[TBL] [Abstract][Full Text] [Related]
34. The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer.
Winslow S; Lindquist KE; Edsjö A; Larsson C
BMC Cancer; 2016 Nov; 16(1):841. PubMed ID: 27809802
[TBL] [Abstract][Full Text] [Related]
35. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
Rody A; Holtrich U; Pusztai L; Liedtke C; Gaetje R; Ruckhaeberle E; Solbach C; Hanker L; Ahr A; Metzler D; Engels K; Karn T; Kaufmann M
Breast Cancer Res; 2009; 11(2):R15. PubMed ID: 19272155
[TBL] [Abstract][Full Text] [Related]
36. State of the science: molecular classifications of breast cancer for clinical diagnostics.
Robison JE; Perreard L; Bernard PS
Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
[TBL] [Abstract][Full Text] [Related]
37. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes.
Hanker LC; Rody A; Holtrich U; Pusztai L; Ruckhaeberle E; Liedtke C; Ahr A; Heinrich TM; Sänger N; Becker S; Karn T
Breast Cancer Res Treat; 2013 Jan; 137(2):407-16. PubMed ID: 23242614
[TBL] [Abstract][Full Text] [Related]
39. Multi-gene signature of microcalcification and risk prediction among Taiwanese breast cancer.
Tsai HT; Huang CS; Tu CC; Liu CY; Huang CJ; Ho YS; Tu SH; Tseng LM; Huang CC
Sci Rep; 2020 Oct; 10(1):18276. PubMed ID: 33106505
[TBL] [Abstract][Full Text] [Related]
40. Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.
Callari M; Cappelletti V; D'Aiuto F; Musella V; Lembo A; Petel F; Karn T; Iwamoto T; Provero P; Daidone MG; Gianni L; Bianchini G
Clin Cancer Res; 2016 Jan; 22(2):337-45. PubMed ID: 26423797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]